Necrotising fasciitis of the shoulder in association with rheumatoid arthritis treated with etanercept: A case report

Journal of Medical Case Reports

Volumn 4, Issue , 2010, Pages

  Smyth, Andrew ^a,b   Houlihan, Diarmaid D ^a,b   Tuite, Helen ^a,b   Fleming, Catherine ^a,b   O'Gorman, Thomas A ^a  

^a UNIVERSITY HOSPITAL GALWAY   (Ireland)

^b NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; C REACTIVE PROTEIN; CEFOTAXIME; CIPROFLOXACIN; CLINDAMYCIN; ETANERCEPT; FLUCLOXACILLIN; GADOLINIUM; METRONIDAZOLE; PENICILLIN G; VANCOMYCIN;

ADULT; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIAL ARTHRITIS; CASE REPORT; CAUCASIAN; COMPUTER ASSISTED TOMOGRAPHY; CONVALESCENCE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE COURSE; EDEMA; ERYTHEMA; FOLLOW UP; HUMAN; MALE; MORTALITY; NECK PAIN; NECROTIZING FASCIITIS; NEUTROPHILIA; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOMYELITIS; PRIORITY JOURNAL; RANGE OF MOTION; RECURRENT DISEASE; RHEUMATOID ARTHRITIS; SHOULDER; SHOULDER PAIN; SKIN ABSCESS; SUBCUTANEOUS FAT; TUBERCULOSIS;

EID: 78249240906     PISSN: None     EISSN: 17521947     Source Type: Journal    
DOI: 10.1186/1752-1947-4-367     Document Type: Article

References (10)

1. A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis. Bathon JM, Martin RW, Fleischmann RM, Tesser JR, Schiff MH, Keystone EC, Genovese MC, Wasko MC, Moreland LW, Weaver AL, Markenson J, Finck BK, N Engl J Med 2000 343 1586 1593 10.1056/NEJM200011303432201 11096165 (Pubitemid 32162981)
2. Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group. Fisher CJ Jr, Agosti JM, Opal SM, Lowry SF, Balk RA, Sadoff JC, Abraham E, Schein RM, Bengamin E, N Engl J Med 1996 334 1697 1702 10.1056/NEJM199606273342603 8637514 (Pubitemid 26193621)
3. Anticytokine therapy - a new era in the treatment of rheumatoid arthritis? O'Dell JR, N Engl J Med 1999 340 310 312 10.1056/NEJM199901283400411 9920958 (Pubitemid 29063276)
4. Safety of infliximab and other biologic agents in the inflammatory bowel diseases. Reddy JG, Loftus EV Jr, Gastroenterol Clin North Am 2006 35 837 855 10.1016/j.gtc.2006.09.008 17129816 (Pubitemid 44802970)
5. Tumour necrosis factor-alpha and tuberculosis: guidance from the National TB Advisory Committee. Kavanagh PM, Gilmartin JJ, O'Donnell J, O'Flanagan D, Ir Med J 2008 101 6 7 18369014
6. Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden. Askling J, Fored CM, Brandt L, Baecklund E, Bertilsson L, Coster L, Geborek P, Jacobsson LT, Lindblad S, Lysholm J, Rantapaa-Dahlqvist S, Sazne T, Romanus V, Klareskog L, Feltelius N, Arthritis Rheum 2005 52 1986 1992 10.1002/art.21137 15986370 (Pubitemid 40994319)
7. Anti-tumor necrosis factor alpha therapy and the risk of serious bacterial infections in elderly patients with rheumatoid arthritis. Schneeweiss S, Setoguchi S, Weinblatt ME, Katz JN, Avorn J, Sax PE, Levin R, Solomon DH, Arthritis Rheum 2007 56 1754 1764 10.1002/art.22600 17530704 (Pubitemid 47110375)
8. Serious bacterial infections in patients with rheumatoid arthritis under anti-TNF-alpha therapy. Kroesen S, Widmer AF, Tyndall A, Hasler P, Rheumatology (Oxford) 2003 42 617 621 10.1093/rheumatology/keg263 12709536 (Pubitemid 37220869)
9. Necrotizing fasciitis: a fourteen-year retrospective study of 163 consecutive patients. Childers BJ, Potyondy LD, Nachreiner R, Rogers FR, Childers ER, Oberg KC, Hendricks DL, Hardesty RA, Am Surg 2002 68 109 116 11842952 (Pubitemid 44943208)
10. Necrotizing fasciitis of the chest and abdominal wall arising from an empyema. Praba-Egge AD, Lanning D, Broderick TJ, Yelon JA, J Trauma 2004 56 1356 1361 10.1097/01.TA.0000042157.00868.2E 15211151 (Pubitemid 38901857)